News

CancerVAX Announces Research Program

May 26, 2021

CancerVAX, Inc., a developer of immunotherapy cancer treatments that use the body’s immune system to fight cancer, today announced that it has entered into a sponsored research agreement with UCLA…

CancerVAX Closes Series A Funding Round

March 30, 2021

CancerVAX, Inc., a developer of immunotherapy cancer treatments that use the body’s immune system to fight cancer, today announced it has closed its $2 million series A funding round…

CancerVAX Launched

March 23, 2021

CancerVAX, Inc., a developer of immunotherapy cancer treatments that use the body’s immune system to fight cancer, today announced the formation of the Company by Lindsay Mann, an experienced healthcare executive….